​

PTC Therapeutics Ownership | Who Owns PTC Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

PTC Therapeutics Ownership Summary

PTC Therapeutics is owned by 102.46% institutional investors, 2.34% insiders. Vanguard group is the largest institutional shareholder, holding 11.73% of PTCT shares. Vanguard Health Care Inv is the top mutual fund, with 6.26% of its assets in PTC Therapeutics shares.

PTCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPTC Therapeutics102.46%2.34%-4.80%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group8.97M11.73%$274.42M
Wellington management group llp8.21M10.73%$251.02M
Blackrock7.77M10.16%$237.67M
Rtw investments, lp7.39M9.66%$226.08M
Armistice capital6.96M9.10%$212.90M
Cowen and company3.76M4.91%$114.87M
Camber capital management lp3.50M4.58%$107.03M
Janus henderson group2.98M3.90%$91.15M
State street2.75M3.59%$84.07M
Geode capital management1.79M2.34%$54.68M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rtw investments, lp7.39M3.50%$226.08M
Cowen and company3.76M3.16%$114.87M
Camber capital management lp3.50M2.96%$107.03M
Armistice capital6.96M2.68%$212.90M
Tang capital management700.00K2.18%$21.41M
Pdt partners139.38K0.40%$4.26M
Sphera funds management94.32K0.39%$2.88M
Neo ivy capital management40.71K0.24%$1.25M
Jacobs levy equity management1.72M0.22%$52.47M
Vitalstone financial9.37K0.21%$286.44K

Top Buyers

HolderShares% AssetsChange
Goldman sachs group791.16K0.00%311.14K
Jefferies financial group522.89K0.17%250.00K
Jane street group341.83K0.00%247.14K
Nuveen asset management686.52K0.01%219.87K
Blackrock7.77M0.01%207.05K

Top Sellers

HolderShares% AssetsChange
State street2.75M0.00%-1.36M
First trust advisors lp78.60K0.00%-1.36M
Adage capital partners gp300.00K0.02%-970.00K
Wellington management group llp8.21M0.04%-692.96K
Janus henderson group2.98M0.05%-688.26K

New Positions

HolderShares% AssetsChangeValue
Squarepoint ops122.89K0.01%122.89K$3.76M
Vestal point capital, lp90.00K0.21%90.00K$2.75M
Alps advisors59.82K0.01%59.82K$1.83M
Mirae asset global etfs59.70K0.00%59.70K$1.84M
Campbell & co investment adviser57.81K0.15%57.81K$1.77M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Byrne asset management-25.00
Federation des caisses desjardins du quebec-30.00
Innealta capital-36.00
Allspring global investments-47.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242113.43%78,815,809-1.28%1020.94%97-21.77%7319.67%
Jun 30, 20242046.81%79,836,937-6.22%1040.84%12445.88%61-11.59%
Mar 31, 20241916.11%85,134,8170.70%1110.87%85-13.27%6923.21%
Dec 31, 2023180-3.23%84,545,7164.22%1120.98%98-4.85%56-5.08%
Sep 30, 2023186-12.26%81,125,682-0.19%1070.91%103-11.97%59-6.35%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Health Care Inv4.81M6.26%1.42M
Vanguard Total Stock Mkt Idx Inv2.41M3.12%13.63K
iShares Russell 2000 ETF2.04M2.65%-7.85K
Vanguard Small Cap Index1.96M2.55%24.46K
Vanguard Institutional Extnd Mkt Idx Tr1.18M1.53%23.19K
Vanguard Small Cap Growth Index Inv1.11M1.44%47.44K
SPDR® S&P Biotech ETF888.84K1.15%-10.39K
Hartford MidCap Y808.97K1.05%-805.13K
Fidelity Small Cap Index776.55K1.01%3.69K
Franklin Biotechnology Discv A(acc)USD748.23K0.97%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 07, 2025Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICERSell$58.53K
Jan 08, 2025Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICERSell$73.96K
Jan 07, 2025Pauwels Eric CHIEF EXECUTIVE OFFICERSell$72.50K
Jan 08, 2025Pauwels Eric CHIEF EXECUTIVE OFFICERSell$95.05K
Jan 07, 2025Klein Matthew B. CHIEF EXECUTIVE OFFICERSell$97.12K

Insider Transactions Trends

DateBuySell
2024 Q4-23
2024 Q3-1
2024 Q2-6
2024 Q1-22
2023 Q41-

PTCT Ownership FAQ

Who Owns PTC Therapeutics?

PTC Therapeutics shareholders are primarily institutional investors at 102.46%, followed by 2.34% insiders and -4.80% retail investors. The average institutional ownership in PTC Therapeutics's industry, Biotech Stocks , is 109.70%, which PTC Therapeutics falls below.

Who owns the most shares of PTC Therapeutics?

PTC Therapeutics’s largest shareholders are Vanguard group (8.97M shares, 11.73%), Wellington management group llp (8.21M shares, 10.73%), and Blackrock (7.77M shares, 10.16%). Together, they hold 32.62% of PTC Therapeutics’s total shares outstanding.

Does Blackrock own PTC Therapeutics?

Yes, BlackRock owns 10.16% of PTC Therapeutics, totaling 7.77M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.67M$. In the last quarter, BlackRock increased its holdings by 207.05K shares, a 2.74% change.

Who is PTC Therapeutics’s biggest shareholder by percentage of total assets invested?

Rtw investments, lp is PTC Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.50% of its assets in 7.39M PTC Therapeutics shares, valued at 226.08M$.

Who is the top mutual fund holder of PTC Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of PTC Therapeutics shares, with 6.26% of its total shares outstanding invested in 4.81M PTC Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools